Landiolol

Overview

Landiolol is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1742466).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Landiolol expires 24 Apr 2034 and exclusivity 22 Nov 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate

Canonical SMILES

CC1(OC[C@H](O1)COC(=O)CCC2=CC=C(C=C2)OC[C@H](CNCCNC(=O)N3CCOCC3)O)C

InChIKey

WMDSZGFJQKSLLH-RBBKRZOGSA-N